Copyright
©The Author(s) 2021.
World J Hepatol. Apr 27, 2021; 13(4): 472-482
Published online Apr 27, 2021. doi: 10.4254/wjh.v13.i4.472
Published online Apr 27, 2021. doi: 10.4254/wjh.v13.i4.472
Table 4 Model for End-Stage Liver Disease score of cirrhosis patients (n = 174) with or without any complication, n (%)
| < 10 | 10-15 | > 15 | P value | |
| Any complication? | 0.626 | |||
| No | 56 (74.67) | 41 (82.00) | 25 (78.13) | |
| Yes | 19 (25.33) | 9 (18.00) | 7 (21.88) | |
| < 10 | ≥ 10 | |||
| Any complication? | 0.381 | |||
| No | 56 (74.67) | 66 (80.49) | ||
| Yes | 19 (25.33) | 16 (19.51) | ||
| ≤ 15 | > 15 | |||
| Any complication? | 0.949 | |||
| No | 97 (77.60) | 25 (78.13) | ||
| Yes | 28 (22.40) | 7 (21.88) | ||
- Citation: Bernshteyn M, Hu L, Masood U, Sharma AV, Huang D, Sapkota B. Retrospective analysis of complications related to endoscopic retrograde cholangio-pancreatography in patients with cirrhosis vs patients without cirrhosis. World J Hepatol 2021; 13(4): 472-482
- URL: https://www.wjgnet.com/1948-5182/full/v13/i4/472.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i4.472